360 related articles for article (PubMed ID: 19075045)
21. Evaluation of the effects of a high-fat meal on the oral bioavailability of a single dose of preladenant in healthy subjects.
Cutler DL; Tendolkar A; Grachev ID
J Clin Pharmacol; 2012 Nov; 52(11):1698-703. PubMed ID: 22167566
[TBL] [Abstract][Full Text] [Related]
22. Effect of omeprazole on the steady-state pharmacokinetics of voriconazole.
Wood N; Tan K; Purkins L; Layton G; Hamlin J; Kleinermans D; Nichols D
Br J Clin Pharmacol; 2003 Dec; 56 Suppl 1(Suppl 1):56-61. PubMed ID: 14616415
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetics of different dosing strategies of oral posaconazole in patients with compromised gastrointestinal function and who are at high risk for invasive fungal infection.
Cornely OA; Helfgott D; Langston A; Heinz W; Vehreschild JJ; Vehreschild MJ; Krishna G; Ma L; Huyck S; McCarthy MC
Antimicrob Agents Chemother; 2012 May; 56(5):2652-8. PubMed ID: 22290953
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics, safety, and tolerability of oral posaconazole administered in single and multiple doses in healthy adults.
Courtney R; Pai S; Laughlin M; Lim J; Batra V
Antimicrob Agents Chemother; 2003 Sep; 47(9):2788-95. PubMed ID: 12936975
[TBL] [Abstract][Full Text] [Related]
25. Lack of pharmacokinetic drug interaction between oral posaconazole and caspofungin or micafungin.
Krishna G; Vickery D; Ma L; Yu X; Noren C; Power E; Beresford E; Medlock M
J Clin Pharmacol; 2011 Jan; 51(1):84-92. PubMed ID: 20489029
[TBL] [Abstract][Full Text] [Related]
26. Effect of food and ranitidine on saquinavir pharmacokinetics and gastric pH in healthy volunteers.
Kakuda TN; Falcon RW
Pharmacotherapy; 2006 Aug; 26(8):1060-8. PubMed ID: 16863482
[TBL] [Abstract][Full Text] [Related]
27. Understanding variability in posaconazole exposure using an integrated population pharmacokinetic analysis.
Dolton MJ; Brüggemann RJ; Burger DM; McLachlan AJ
Antimicrob Agents Chemother; 2014 Nov; 58(11):6879-85. PubMed ID: 25199779
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics and tolerability of intravenous posaconazole in healthy Chinese volunteers: a randomized, open-label and single-dose study.
Ji W; Zhao H; Yang S; Wen Q; He K
Pharmazie; 2020 Oct; 75(10):491-493. PubMed ID: 33305723
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of a single dose of the antifungal posaconazole as oral suspension in subjects with hepatic impairment.
Moton A; Krishna G; Ma L; O'Mara E; Prasad P; McLeod J; Preston RA
Curr Med Res Opin; 2010 Jan; 26(1):1-7. PubMed ID: 19886860
[TBL] [Abstract][Full Text] [Related]
30. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J
Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetic/pharmacodynamic profile of posaconazole.
Li Y; Theuretzbacher U; Clancy CJ; Nguyen MH; Derendorf H
Clin Pharmacokinet; 2010 Jun; 49(6):379-96. PubMed ID: 20481649
[TBL] [Abstract][Full Text] [Related]
32. Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.
Derks M; Kawamura H; Abt M; Meneses-Lorente G; Phelan M; Ishikawa T
Clin Ther; 2011 Jun; 33(6):754-65. PubMed ID: 21704240
[TBL] [Abstract][Full Text] [Related]
33. Pharmacokinetics and safety study of posaconazole intravenous solution administered peripherally to healthy subjects.
Kersemaekers WM; van Iersel T; Nassander U; O'Mara E; Waskin H; Caceres M; van Iersel ML
Antimicrob Agents Chemother; 2015 Feb; 59(2):1246-51. PubMed ID: 25512407
[TBL] [Abstract][Full Text] [Related]
34. Effects of Food and Omeprazole on a Novel Formulation of Super Bioavailability Itraconazole in Healthy Subjects.
Lindsay J; Mudge S; Thompson GR
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297369
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic properties of rosuvastatin after single-dose, oral administration in Chinese volunteers: a randomized, open-label, three-way crossover study.
Li Y; Jiang X; Lan K; Zhang R; Li X; Jiang Q
Clin Ther; 2007 Oct; 29(10):2194-203. PubMed ID: 18042475
[TBL] [Abstract][Full Text] [Related]
36. Supersaturation and Precipitation of Posaconazole Upon Entry in the Upper Small Intestine in Humans.
Hens B; Brouwers J; Corsetti M; Augustijns P
J Pharm Sci; 2016 Sep; 105(9):2677-2684. PubMed ID: 26505884
[TBL] [Abstract][Full Text] [Related]
37. Posaconazole plasma concentrations in critically ill patients.
Ray J; Campbell L; Rudham S; Nguyen Q; Marriott D
Ther Drug Monit; 2011 Aug; 33(4):387-92. PubMed ID: 21654350
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral posaconazole on the pharmacokinetics of cyclosporine and tacrolimus.
Sansone-Parsons A; Krishna G; Martinho M; Kantesaria B; Gelone S; Mant TG
Pharmacotherapy; 2007 Jun; 27(6):825-34. PubMed ID: 17542765
[TBL] [Abstract][Full Text] [Related]
39. Disposition of posaconazole after single oral administration in large falcons (Falco spp): Effect of meal and dosage and a non-compartmental model to predict effective dosage.
Azmanis P; Pappalardo L; Sara ZAJ; Silvanose C; Naidoo V
Med Mycol; 2021 Sep; 59(9):901-908. PubMed ID: 33891699
[TBL] [Abstract][Full Text] [Related]
40. Effect of posaconazole on the pharmacokinetics of fosamprenavir and vice versa in healthy volunteers.
Brüggemann RJ; van Luin M; Colbers EP; van den Dungen MW; Pharo C; Schouwenberg BJ; Burger DM
J Antimicrob Chemother; 2010 Oct; 65(10):2188-94. PubMed ID: 20667889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
